Columbia University has received a $58.4 million grant from the NIH's National Center for Advancing Translational Sciences to expand its work in translational research.
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
Scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for vision loss in patient-derived stem cells.
In a case demonstrating the promise of precision medicine, a 20-month-old girl suffering from a rare neurodegenerative disease was diagnosed by exome sequencing and successfully treated.
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.